Novartis | NVS - Interessi Passivi Sul Debito





Interessi Passivi Sul Debito Cambiamento Data
AbbVie USD 688M 58M 2026-09
Amgen USD 653M 94.99B 2026-09
AstraZeneca USD 371M 31M 2026-09
Bausch Health Companies USD 398M 2M 2026-09
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 403M 4M 2026-09
Canopy Growth CAD 12.68M 364K 2026-06
Corcept Therapeutics USD 1.03B 145.32M 2026-09
Drreddys Laboratories INR 1.06B 113M 2026-03
Eli Lilly USD 316M 201.3M 2026-09
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Glaxosmithkline GBP 264.74M 72.01M 2026-09
J&J USD 43M 25M 2026-03
Merck USD 525M 46M 2026-06
Novartis USD 468M 6M 2026-09
Novartis USD 281M 8M 2025-09
Pacira USD 112.4M 108.78M 2026-09
Perrigo USD 7.48B 124.6M 2026-09
Pfizer USD 662M 5M 2026-09
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 13.94M 2.52M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 222M 65M 2026-09
Sanofi EUR -25M 99.78M 2025-12
Supernus Pharmaceuticals USD 718K 1.6M 2026-09
Zoetis USD 62M 1000K 2026-09